Mutation Analysis Laboratory Services

Added: Jan 25, 2011 6:42 pm Modified: Feb 23, 2011 5:56 pmTrack Changes The date and time for receipt of responses to combined synopsis/solicitation 11-000872 has been amended from February 23 2011, 12:00PM to February 28, 2011, 3:00PM, eastern standard time. Facsimile submissions are not authorized and collect calls will not be accepted. Submit offers to Malinda Dehner at the address listed in this notice, or dehnerm@cc.nih.gov.

Added: Feb 07, 2011 5:01 pm The following response is provided to the question submitted by vendor in reference to solicitation# 11-000872:



Question: By the criteria outlined in the synopsis and Standards of Work, with 80% of testing being performed on-site; one or all of the schedules may not have a bid. If this is the case, can (VENDOR) provide a bid that is below the minimum 80% criteria?



Answer: For each applicable schedule, Offerors must show that they can perform at least 80% of the tests at their on-site laboratory. The offeror may choose to bid on one, two or all three test schedules if they can perform 80% or more of the tests on the selected schedule. If the proposal does not meet the on-site threshold of 80% or greater on the schedule chosen, the proposal will not be considered for further evaluation.

Added: Jan 25, 2011 6:42 pm Modified: Feb 07, 2011 4:51 pmTrack Changes The date and time for receipt of responses to combined synopsis/solicitation 11-000872 has been amended from February 15, 2011, 3:00PM to February 23, 2011, 12:00PM, eastern standard time. An acknowlegement of Amendment No. 1 to the subject RFP should be included with the vendors response to this RFP. Facsimile submissions are not authorized and collect calls will not be accepted. Submit offers to Malinda Dehner at the address listed in this notice, or dehnerm@cc.nih.gov.

Added: Jan 25, 2011 6:42 pm This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. This is a not a small business set aside. It is the intent of the Government to issue multiple awards. The contract type is fixed price, based upon fixed prices for each test. NAICS 621511, size 13.5M.



The solicitation number is 11-000872 and is issued as a request for proposal (RFP). The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-46. The Clinical Center has a requirement for genetic/mutation testing. Offerors are referred to the attached Statement of Work for requirements. The period of performance is for a one year (12 month) base period. All tests will be requested from the Clinical Center in Bethesda, Maryland.



Interested parties who meet the requirements are invited to submit a proposal, including statements of how the proposal will meet the Government requirements. All information furnished shall be legible, typed and must contain sufficient detail to allow the government to evaluate and determine best value, see Evaluation/Award Criteria-SOW. Technical and past performance combined will be significantly more important than cost or price. Please submit the technical and cost proposals separately, clearly labeled.



Offerors are requested to complete one or more of the attached tables, listing the tests and proposed cost. Offerors must clearly specify the list of test(s)/schedule(s) for which they are submitting an offer. Three lists of tests are attached and labeled accordingly: 1. Mutation Analysis Schedule I. 2. Mutation Analysis Schedule II. 3. Mutation Analysis Schedule III. At a minimum, the offeror is required to propose pricing on >=80% of the tests listed on each of the individual lists.



The solicitation incorporates the provisions at FAR 52.212-1, INSTRUCTIONS TO OFFERORS-COMMERCIAL ITEMS-DEVIATION FOR SIMPLIFIED ACQUISITIONS, FAR 52.212-2, EVALUATION-COMMERCIAL ITEMS. Specific evaluation criteria are listed within the statement of work, titled Evaluation/Award Criteria. FAR 52.212-3, Offeror Representations and Certifications-Commercial Items-with duns number addendum. Or, the offeror may provide documentation that the vendor is current and registered in Online Representations and Certifications Application (ORCA) on www.bpn.gov.



In addition, the resulting contract will incorporate the requirements of the clause at FAR 52.212-4 Contract Terms and Conditions-Commercial Items, and the requirements contained in paragraphs (a) and (d) of the clause at FAR 52.212-5, Contract Terms and Conditions Required to Implement Statues or Executive Orders-Commercial Items-deviation for simplified acquisitions. The contract will also incorporate the following FAR clauses cited in paragraphs (b) and (c) of the latter clause: FAR 52.222-26, EQUAL OPPORTUNITY; FAR 52.222-35, AFFIRMATIVE ACTION FOR SPECIAL DISABLED AND VIETNAM ERA VETERANS; FAR 52.222-36, AFFIRMATIVE ACTION FOR HANDICAPPED WORKERS; FAR 52.222-37, EMPLOYMENT REPORTS ON SPECIAL DISABLED VETERANS OF VIETNAM ERA;



FAR 52.232-18 AVAILABILITY OF FUNDS, applies to this requirement.



All inquiries regarding this solicitation must be submitted in writing to dehnerm@cc.nih.gov by February 08, 2011, 12:00PM. All questions and responses will be posted via the fedbizopps within 3 business days of the original inquiry. Offers and related materials must be received in this office by 3:00 p.m. EST on February 15, 2011. Facsimile submissions are not authorized and collect calls will not be accepted. Submit offers to Malinda Dehner at the address listed in this notice, or dehnerm@cc.nih.gov. Please reference the solicitation number, 11-000872 on your offer. Performance will be accomplished at NIH, Bethesda, MD. All expenses incurred as a result of this solicitation, is the absolute responsibility of the offeror.



Attachments

1) Table of Tests-Mutation Analysis Schedule I

2) Table of Tests-Mutation Analysis Schedule II

3) Table of Tests-Mutation Analysis Schedule III

4) Statement of Work

5) NIH IT Security Provisions and Terms and Conditions